What is more, it confirmed that S100A8 played a crucial role in the maintenance of the stemness features of tumor cells, accompanied by p38, which could also hinder the killing process of Sec C. This suggests that Sec C or its homologs have the potential to be developed as efficacious anti-cancer prodrugs after a series of structural renovations. This evidence concerns the gene S100A8 and neoplasm.